What Drugs Cause Secondary Intracranial Hypertension?
At a Glance
Certain medications can trigger secondary intracranial hypertension (SIH), causing elevated pressure in the brain. The most common pharmacological triggers include tetracycline antibiotics, systemic retinoids, high-dose Vitamin A, and the rapid withdrawal of systemic corticosteroids.
Yes, certain medications can cause elevated pressure in the brain. When increased cerebrospinal fluid pressure is triggered by a specific medication or external agent, it is diagnosed as secondary intracranial hypertension (SIH) rather than idiopathic intracranial hypertension (IIH) [1]. The most common pharmacological triggers include tetracycline antibiotics, retinoids (such as systemic acne medications and high-dose vitamin A), and the use or sudden withdrawal of systemic corticosteroids [2]. Identifying whether a current or very recent medication is contributing to your symptoms is critical, because safely stopping the offending drug is often the most direct path to achieving remission [1][3].
Common Medication Triggers
Several specific classes of medication are known to interfere with how the body produces or absorbs cerebrospinal fluid, leading to a buildup of pressure. These triggers are typically medications you are currently taking or have stopped very recently, rather than drugs you took years ago.
Tetracycline Antibiotics
Tetracyclines are a class of antibiotics frequently prescribed for acne, rosacea, and certain bacterial infections. Medications in this family are among the most recognized triggers for secondary intracranial hypertension [4].
- Doxycycline and minocycline are the most common variants linked to this condition [5].
- Oxytetracycline has also been associated with acute drug-induced pressure increases [6].
While the precise reason these antibiotics increase brain fluid pressure is still being studied, the association is established well enough that doctors closely monitor patients taking them for neurological or visual changes [7].
Retinoids and Vitamin A
Retinoids are compounds derived from Vitamin A, widely used in dermatology for severe skin conditions. Both prescription medications and over-the-counter supplements can act as triggers:
- Systemic retinoids, such as isotretinoin (often known by the brand name Accutane), are well-documented causes of drug-induced intracranial hypertension [8].
- High-dose Vitamin A supplements, sometimes found in vision or skin-health vitamins, can lead to the same fluid buildup [2].
- Note on topical treatments: While there are rare case reports involving topical vitamin A derivatives (creams applied to the skin), the systemic absorption is generally very low. The primary risk lies with oral medications and high-dose supplements [8].
Critical Safety Warning: Taking systemic retinoids (like isotretinoin) and tetracycline antibiotics at the same time is contraindicated. Because both are commonly prescribed for severe acne, patients may inadvertently overlap them, which drastically increases the risk of developing intracranial hypertension [8].
Systemic Corticosteroids
Corticosteroids (such as prednisone) are powerful anti-inflammatory drugs used for a variety of systemic illnesses. Intracranial hypertension has a unique, counterintuitive relationship with these medications:
- It can sometimes occur during active, prolonged use of the steroid [2].
- More characteristically, it is triggered by the rapid withdrawal or tapering of the medication after long-term use, a phenomenon sometimes referred to as “corticosteroid withdrawal pseudotumor cerebri” [2].
Important: Because the rapid withdrawal of steroids can cause the pressure spike (and lead to a life-threatening adrenal crisis), you must never attempt to abruptly stop taking a corticosteroid on your own to see if your symptoms improve. Any tapering must be strictly managed by your doctor.
Why Identifying Triggers Matters
Secondary intracranial hypertension is clinically identical to idiopathic intracranial hypertension. A patient will experience the exact same symptoms—such as severe headaches, whooshing noises in the ears (pulsatile tinnitus), and swelling of the optic nerves (papilledema) [1].
However, the approach to treatment is fundamentally different. For idiopathic cases, the standard of care relies on weight management and long-term fluid-reducing medications. For secondary cases, safely discontinuing or adjusting the triggering medication—under a doctor’s close supervision—is the primary treatment [2]. While temporary treatment with pressure-lowering medications like acetazolamide may still be needed to protect your vision while the drug leaves your system, identifying the root cause can often prevent the need for lifelong IIH management [3].
Common questions in this guide
Which antibiotics cause secondary intracranial hypertension?
Can acne medicine increase pressure in the brain?
Will stopping the medication cure secondary intracranial hypertension?
Why does stopping a steroid cause intracranial hypertension?
Is Vitamin A linked to high intracranial pressure?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Given my current medication list, including over-the-counter supplements, are there any known triggers for increased intracranial pressure?
- 2.If we identify a medication that might be causing my symptoms, what is the safest way to taper off or switch to an alternative?
- 3.How long after safely stopping a potential trigger medication should we expect my intracranial pressure and symptoms to improve?
- 4.Should I be taking any interim medications, like acetazolamide, to protect my vision while we wait for the trigger medication to leave my system?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (8)
- 1
Phenotyping non-idiopathic pseudotumor cerebri syndrome - A prospective cohort study.
Svart K, Jensen RH, Høgedal L, et al.
Cephalalgia : an international journal of headache 2022; (42(14)):1510-1520 doi:10.1177/03331024221120073.
PMID: 35983777 - 2
Drug-Induced Intracranial Hypertension: A Systematic Review and Critical Assessment of Drug-Induced Causes.
Tan MG, Worley B, Kim WB, et al.
American journal of clinical dermatology 2020; (21(2)):163-172 doi:10.1007/s40257-019-00485-z.
PMID: 31741184 - 3
Delayed Development of Intracranial Hypertension After Discontinuation of Tetracycline Treatment for Acne Vulgaris.
Law C, Yau GL, ten Hove M
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2016; (36(1)):67-9 doi:10.1097/WNO.0000000000000301.
PMID: 26397465 - 4
Tetracycline-, Doxycycline-, Minocycline-Induced Pseudotumor Cerebri and Esophageal Perforation.
Angelette AL, Rando LL, Wadhwa RD, et al.
Advances in therapy 2023; (40(4)):1366-1378 doi:10.1007/s12325-023-02435-y.
PMID: 36763302 - 5
Doxycycline-induced idiopathic intracranial hypertension in a patient with Lyme disease.
Campetti D, Kelly A, Diaz K
JAAPA : official journal of the American Academy of Physician Assistants 2021; (34(3)):35-37 doi:10.1097/01.JAA.0000731504.17394.29.
PMID: 33600108 - 6
Fulminant intracranial hypertension secondary to oxytetracycline requiring urgent ventriculo-peritoneal shunt insertion.
Uberti M, Mostofi A, Nitkunan A, et al.
Neuro-Chirurgie 2021; (67(6)):621-623 doi:10.1016/j.neuchi.2021.01.012.
PMID: 33529696 - 7
Increased Incidence of Pseudotumor Cerebri Syndrome Among Users of Tetracycline Antibiotics.
Passi SF, Butcher R, Orme DR, et al.
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 2022; (42(3)):323-327 doi:10.1097/WNO.0000000000001536.
PMID: 35427251 - 8
Intracranial hypertension associated with topical tretinoin use.
Gasparian S, Geng X, Hawy E
American journal of ophthalmology case reports 2021; (23()):101130 doi:10.1016/j.ajoc.2021.101130.
PMID: 34169180
This information about medication-induced intracranial hypertension is for educational purposes only. Never stop or adjust your prescribed medications, especially corticosteroids, without direct guidance from your healthcare provider.
Get notified when new evidence is published on Idiopathic intracranial hypertension.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.